|Year : 2021 | Volume
| Issue : 3 | Page : 267-269
In vitro antimicrobial effect of chloroaluminum phthalocyanine nanoemulsion on periodontal bacteria
Laura Patricia Lloreda Rey1, Sandra Milena Leal Pinto2, Luis Alexandre Muelhmann3, Luz Mery Méndez2, Laura Viviana Herrera Sandoval4
1 Faculty of Health Sciences, University of Santander; Oral Medicine Clinic, Oral Vida S.A.S, Bucaramanga, Colombia
2 Faculty of Health Sciences, University of Santander, Bucaramanga, Colombia
3 Laboratory of Nanoscience and Immunology, Faculty of Ceilandia, University of Brasilia, Brasilia/DF, Brazil
4 Department of Basic Sciences, Stomatognathic System and Morphophysiology Research Group, Santo Tomás University, Bucaramanga, Colombia
|Date of Submission||18-Jun-2020|
|Date of Decision||25-Dec-2020|
|Date of Acceptance||26-Jan-2021|
|Date of Web Publication||04-May-2021|
Sandra Milena Leal Pinto
Street 70 No 55-210, University of Santander, Faculty of Health Sciences, Bucaramanga
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Context: Nowadays, complementary therapies are necessary for a major removal of microbial subgingival biofilm in the conventional treatment of periodontitis. Research has suggested the use of photodynamic therapy (PDT) as a promising therapy to manage oral cavity infections. This project proposes a new combination of photosensitizer chloroaluminum phthalocyanine and nanoemulsion as a strategy for improving bioactivity. The main purpose of this in vitro study was to evaluate the antimicrobial activity of nanoemulsion ClAlPc (ClAlPc-NE) on relevant periodontal bacteria before and after PDT. Materials and Methods: The phototoxic and antibacterial effect of ClAlPc-NE was evaluated against epithelial cells derived from an African green monkey kidney using the colorimetric method with salt tetrazolium 3-(4.5-dimethylthiazolyl-2)-2.5-Diphenyltetrazolium bromide (Merck) and periodontopathogen bacteria (Porphyromonas gingivalis (ATCC 33277), Aggregatibacter actinomycetemcomitans (ATCC 33384), and Prevotella intermedia (ATCC 25611) using the plate microdilution method according to Tavares et al., 2018, respectively. The light source used for the PDT was a LED laser (400–700 nm); the cells were irradiated for 2 min using 4.83 joules/cm2. Results: Antibacterial effect of NE-PcAlCl against P. intermedia with minimum inhibitory concentration (MIC) 0.63 μM after TFD was determined. In the case of P. gingivalis and A. actinomycetemcomitans, no biological activity was found after PDT (MIC > 20 μM) under-evaluated experimental conditions. On the other hand, the ClAlPc-free and ClAlPc-NE cells were phototoxic on epithelial cells. Conclusion: The results helped to identify the potential use of ClAlPc-NE to inhibit the periodontal bacterial and additional studies are being developed.
Keywords: Antimicrobial activity, nanoemulsion, periodontal bacteria, periodontitis, photodynamic therapy, phthalocyanine
|How to cite this article:|
Rey LP, Pinto SM, Muelhmann LA, Méndez LM, Sandoval LV. In vitro antimicrobial effect of chloroaluminum phthalocyanine nanoemulsion on periodontal bacteria. J Indian Soc Periodontol 2021;25:267-9
|How to cite this URL:|
Rey LP, Pinto SM, Muelhmann LA, Méndez LM, Sandoval LV. In vitro antimicrobial effect of chloroaluminum phthalocyanine nanoemulsion on periodontal bacteria. J Indian Soc Periodontol [serial online] 2021 [cited 2021 Dec 8];25:267-9. Available from: https://www.jisponline.com/text.asp?2021/25/3/267/315438
| Introduction|| |
Periodontitis is a global health problem that includes a complex multifactorial group of diseases associated with subgingival biofilm, it also causes the destruction of the tooth-supporting structure and can lead to tooth loss.
In the subgingival microbial community, bacteria such as Porphyromonas gingivalis, Prevotella intermedia, and Agreggatibacter actinomycetemcomitans are frequent. They have been called “key pathogens” and have an important role in the dysbiosis of periodontal tissues.
Scaling technique and root planning are conventional periodontitis treatments that could be combined with local or systemic antibiotics. However, the effectiveness of this kind of procedure to completely control this pathology are variable; therefore, adjuvant therapy as a treatment of periodontal diseases including antimicrobial photodynamic therapy (aPDT) has been introduced as a therapeutic alternative since clinical studies are in progress.,
The antimicrobial PDT mechanism is based on cellular toxicity through singlet oxygen and free radicals generated by a light-activated photosensitizer (PS). In dentistry, aPDT with a conventional PS such as toluidine blue (TBO) and methylene blue are emerging therapies in oral infectious treatments including chronical periodontitis, however further studies are necessary. Aluminum-phthalocyanine is a second-generation PS with high absorption of light at longer wavelengths that allows penetration to deeper tissues, which is important for the activation and antimicrobial effect. This PS is highly potent for PDT, but it is a hydrophobic molecule that aggregates in aqueous media, an event that leads to quenching phenomena. This extinguishes any photodynamic activity of this PS.
This project proposes to dissolve this PS in the oil nanodroplets of the nanoemulsion maintaining the photodynamic activity in biological fluids. AlClPc has shown promising results in other biological model. Therefore, the objective of this in vitro study was to evaluate the antimicrobial activity of nanoemulsion ClAlPc (ClAlPc-NE) before and after PDT on relevant periodontal bacteria.
| Materials and Methods|| |
The phototoxic and antibacterial effect of ClAlPc-NE prepared by Muelhmann et al. was evaluated against epithelial cells derived from an African green monkey kidney (VERO, ATCC CCL-81) using the colorimetric method with salt tetrazolium 3-(4. 5-dimethylthiazolyl-2)-2. 5-Diphenyltetrazolium bromide (Merck) and periodontopathogen bacteria (P gingivalis (ATCC 33277), A. actinomycetemcomitans (ATCC 33384), and P. intermedia (ATCC 25611) using the plate microdilution method according to Tavares et al., 2018, respectively. The nanoemulsion vehicle, ClAlPc (Sigma-Aldrich, St. Louis, MO, USA) dissolved in DMSO and 2% chlorhexidine gluconate from Ultra dent were evaluated as a reference. The light source used for PDT was a LED laser (660 nm), the cells were irradiated for 2 min using 4.83 joules/cm2. The treatment with the formulation was carried out for 24 h before and after irradiation. Finally, the results were expressed as the cytotoxic concentration 50 (CC50) calculated using the XLFit5 (IBM) for phototoxicity and as a minimum inhibitory concentration (MIC) and bactericidal (MBC) for antibacterial activity assays. Experiments were performed by triplicate and controls were evaluated without irradiation.
| Results|| |
Biological activity results about formulations on periodontal pathogens and Vero cells are presented below [Table 1]. The nonencapsulated ClAlPc and nanoemulsion showed to be phototoxic for Vero cells without significant differences (P = 0.100) after PDT. Chlorhexidine, used as a reference drug, also showed a toxic effect independent of PDT. In addition, a biological effect of the formulations (ClAlPc-DMSO, ClAlPc-NE, and vehicle) without PDT was not demonstrated.
|Table 1: Biological activity of chloroaluminum phthalocyanine formulations against periodontopathogens and mammalian cells after photodynamic therapy|
Click here to view
On the other hand, no antibacterial effect was observed after PDT against A. actinomycetemcomitans with any of the formulations evaluated. In the case of P. gingivalis, inhibition was observed after the exposure with ClAlPc-DMSO and PDT (MIC 1.66 μM). In contrast, P. intermedia was six times more susceptible to treatment with ClAlPc-NE compared to ClAlPc-DMSO after PDT. Chlorhexidine showed antibacterial effect against the three strains evaluated with MIC between 330.78 and 2646.25 μM independent of PDT[Table 1].
| Discussion|| |
The search on aPDT as a complementary therapy to conventional periodontitis treatments seems to be therapeutically useful. Therefore, the incorporation of a new PS and nanotechnologies are a promising option.
The in vitro effectiveness of NE-ClAlPc against P. intermedia was demonstrated, after PDT. However, this same effect was not observed against P. gingivalis and A. actinomycetemcomitans. The bioactivity of PS conveyed in NE has not been previously reported for oral microorganisms; therefore, this project innovates and develops a new alternative of TDF for EP.
Moreover, PDT with ClAlPc-DMSO slightly inhibited with MIC and MBC of 1,66 μM but without effect in NE, endogenous porphyrins in black-pigmented oral bacteria could interact with PS and explain different susceptibilities to PDT.
The effect to PDT against A. actinomycetemcomitans was contradicted with previous reports with PS as a TBO, MB, and Safranine O, among others. However, some studies suggest that this effect depends on system irradiation parameters, internalization, and subsequent activity of the PS.
Similarly, NE-ClAlPc showed cytotoxicity in vitro in vero cells after PDT. These results indicate the internalization of the PS and determine the optimization of the irradiation scheme to determine the selectivity of the Nano system. Similar effects have been reported with this same NE system on lung carcinoma cells (MCF-7). In contrast, ClAlPc nanoparticles demonstrated variability of the cell line-dependent cytotoxic effect (4T1, MCF-7, NIH/3T3, and MCF-10A) being the nontumor cells most susceptible to PDT by AlClPc.
In this survey, we evaluated the effects in planktonic cells, which can be referred to as one of the restrictions in our study. Furthermore, we did not measure a wide range of concentrations for ClAlPc-NE, nor radiations with different wavelengths or times. However, the general results of this study showed the need to complement the experimentation with TDF + ClAlPc-NE in future, probably in biofilm models.
This study concluded that ClAlPc associated with nanoemulsion showed significant antibacterial effect against P. intermedia, after PDT. Complementary studies in oral cell lines would be important to measure the selectivity of the nanoemulsion.
The authors would like to thank at MSc. Libeth Yajaira Criado by support in consolidating the research idea, at Group of semiconductors and magnetic nanostructures of the Physics Institute from the University of Brasilia and Professor Ricardo Bentes Azevedo for the manufacture of the LED and donation thereof, respectively.
Financial support and sponsorship
This research was supported by Universidad de Santander by for financing project PICF0117404581855EJ and Universidad Santo Tomás of Bucaramanga through internal research announcement GIFQAAMBODONTP52017.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Caton GC, Armitage G, Berglundh T, Chapple IL, Jepsen S, Kornman KS et al
. A new classification scheme for periodontal and peri-implant diseases, conditions-Introduction, and key changes from the 1999 classification. J Clin Periodontol 2018;45:S1-8.
Kikuchi T, Mogi M, Okabe I, Okada K, Goto H, Sasaki Y, et al
. Adjunctive application of antimicrobial photodynamic therapy in nonsurgical periodontal treatment: A review of literature. Int J Mol Sci 2015;16:24111-26.
Muehlmann LA, Rodrigues MC, Longo JP, Garcia MP, Py-Daniel KR, Veloso AB, et al
. Aluminium-phthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro
activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells. J Nanobiotechnology 2015;13:36.
Tavares LJ, de Avila ED, Klein MI, Panariello BHD, Spolidório DMP, Pavarina AC. Antimicrobial photodynamic therapy alone or in combination with antibiotic local administration against biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis. J Photochem Photobiol B 2018;188:135-45.
Moslemi N, Rouzmeh N, Shakerinia F, Bahador A, Soleimanzadeh Azar P, Kharazifard MJ, et al
. Photodynamic inactivation of Porphyromonas gingivalis
utilizing radachlorin and toluidine blue o as photosensitizers: An in vitro
study. J Lasers Med Sci 2018;9:107-12.